The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease

被引：0

作者：

Pennisi, G. ^{[1
]}

Di Maria, G. ^{[2
]}

Wong, V. Wai-Sun ^{[3
]}

de Ledinghen, V. ^{[4
]}

Sebastiani, G. ^{[5
]}

Vigano, M. ^{[6
]}

Fracanzani, A. L. ^{[7
]}

Miele, L. ^{[8
]}

Bugianesi, E. ^{[9
]}

Ekstedt, M. ^{[10
]}

D'Ambrosio, R. ^{[11
]}

Schepis, F. ^{[12
,13
]}

Marra, F. ^{[14
,15
]}

Aghemo, A. M. ^{[16
]}

Svegliati-Baroni, G. ^{[17
]}

Persico, M. ^{[18
]}

Valenti, L. ^{[7
,19
]}

Berzigotti, A. ^{[20
]}

George, J. ^{[21
]}

Ravaioli, F. ^{[22
]}

Armandi, A. ^{[9
]}

Calvaruso, V. ^{[1
]}

Enea, M. ^{[2
]}

Lin, H. ^{[3
]}

Infantino, G. ^{[1
]}

Masarone, M. ^{[18
]}

Pugliese, N. ^{[16
]}

Tulone, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

Petta, S. ^{[1
]}

机构：

[1] Univ Palermo, Sect Gastroenterol & Hepatol, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy

[2] Univ Palermo, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy

[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[4] Bordeaux Univ Hosp, Hop Haut Leveque, INSERM U1053, Ctr Invest Fibrose Hepat, Pessac, France

[5] McGill Univ, Div Gastroenterol & Hepatol, Ctr Hlth, Montreal, PQ, Canada

[6] Univ Milan, Osped San Giuseppe, Hepatol Unit, Milan, Italy

[7] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[8] Fdn Policlin Gemelli IRCCS, DiSMeC Dept Sci Med & Chirurg, I-00168 Rome, Italy

[9] Univ Torino, Dept Med Sci, Div Gastroenterol, Turin, Italy

[10] Linkoping Univ, Dept Hlth Med & Caring Sci, Div Diagnost & Specialist Med, Linkoping, Sweden

[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy

[12] Azienda Osped Univ Modena, Div Gastroenterol, Modena, Italy

[13] Univ Modena & Reggio Emilia, Modena, Italy

[14] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy

[15] Res Ctr DENOTHE, Florence, Italy

[16] IRCCS Humanitas Res Hosp, Dept Gastroenterol, Div Internal Med & Hepatol, I-20089 Rozzano, Italy

[17] Univ Politecn Marche, Liver Injury & Transplant Unit, I-60121 Ancona, Italy

[18] Univ Salerno, Internal Med & Hepatol Unit, Scuola Med Salernitana, Dept Med & Surg, Salerno, Italy

[19] Fdn IRCCS Ca Granda Osped Maggiore Policlin IRCCS, Dept Transfus Med, Translat Med, Milan, Italy

[20] Univ Bern, Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland

[21] Univ Sydney, Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia

[22] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷

关键词：

D O I：

10.1016/j.dld.2024.08.005

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OC-01

引用

页码：S316 / S317

页数：2

共 50 条

[21] Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease
Mendoza, Yuly
Cocciolillo, Sila
Chen, Tianyan
Margini, Cristina
Sebastiani, Giada
Berzigotti, Annalisa
Murgia, Giuseppe
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (13) : 3017 - +
[22] THE IMPACT OF LIRAGLUTIDE ON PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE
Lee, Hye Won
So, Jae Eun
Ahn, Sang Hoon
Kim, Seung Up
HEPATOLOGY, 2024, 80
[23] Differential prevalence and prognostic value of metabolic syndrome components among metabolic-dysfunction associated steatotic liver disease (MASLD) patients
Pustjens, Jesse
van Kleef, Laurens
Janssen, Harry L. A.
de Knegt, Robert J.
Brouwer, Willem Pieter
JOURNAL OF HEPATOLOGY, 2024, 80 : S467 - S468
[24] Metabolic-dysfunction associated liver disease in patient with Inflammatory Bowel Disease: Is obesity the major driver of disease progression?
Bracciama, E.
Di Giorgio, F. M.
Melatti, P.
Amato, L. M.
Salerno, I. A.
Ajovalasit, R.
Di Prima, L.
Scalia, S.
Gambadauro, D.
Pennisi, G.
Petta, S.
Cappello, M.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2180 - i2180
[25] Controlled attenuation parameter as an additional tool for the non-invasive prediction of first clinical decompensation in compensated advanced chronic liver disease
Margini, C.
Murgia, G.
Stirnimann, G.
De Gottardi, A.
Semmo, N.
Casu, S.
Bosch, J.
Dufour, J. -F.
Berzigotti, A.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S91 - S92
[26] Recompensation and liver function improvement in patients with decompensated cirrhosis due to metabolic-dysfunction associated steatotic liver disease (MASLD): a retrospective cohort study
Jimenez-Masip, Alba
Broquetas, Teresa
Bassegoda, Octavi
Martinez, Sergio Munoz
Serra, Isabel
Rojo, Diego
Soria, Anna
El Maimouni, Cautar
Carrion, Jose A.
Gines, Pere
Genesca, Joan
Graupera, Isabel
Pericas, Juan Manuel
JOURNAL OF HEPATOLOGY, 2024, 80 : S471 - S471
[27] CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study
Wong, Yu Jun
Li, Jia
Liu, Chuan
Chen, Zhaojin
Chan, Yiong Huak
Putera, Martin
Teh, Kok Ban
Ang, Tiing Leong
Zhao, Lili
Yan, Zhongfang
Kumar, Rahul
Li, Xin
Qi, Xiaolong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (06) : 1043 - 1051
[28] The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C
Al-Omary, Ahmed
Byth, Karen
Weltman, Martin
George, Jacob
Eslam, Mohammed
JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (01) : 33 - 43
[29] IMPROVING SCREENING OF METABOLIC-DYSFUNCTION ASSOCIATED LIVER DISEASE (MASLD) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A QUALITY IMPROVEMENT INITIATIVE
Alenzi, Maram
Razzak, Iyiad Alabdul
Usman, Alya
Mitri, Jad
Chavez, Monica
HEPATOLOGY, 2024, 80 : S449 - S450
[30] Imaging-based assessment of sarcopenia in patients with compensated advanced chronic liver disease: One step further
Ronot, Maxime
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)

← 1 2 3 4 5 →